UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structured care for patients with new oral anticoagulants. Nursing based care of adults with atrial fibrillation

Läkartidningen, 2014-10, Vol.111 (40), p.1720-1722

2014

Volltextzugriff (PDF)

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

Thrombosis and haemostasis, 2011, Vol.105 (2), p.371-378

2011

Volltextzugriff (PDF)

Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.1128-1139

2014

Volltextzugriff (PDF)

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Circulation (New York, N.Y.), 2014-02, Vol.129 (7), p.764-772

2014

Volltextzugriff (PDF)

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Circulation (New York, N.Y.), 2015-01, Vol.131 (2), p.157-164

2015

Volltextzugriff (PDF)

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

The New England journal of medicine, 2013-09, Vol.369 (13), p.1206-1214

2013

Volltextzugriff (PDF)

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis

Journal of thrombosis and haemostasis, 2014-03, Vol.12 (3), p.320-328

2014

Volltextzugriff (PDF)

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

BMJ (Online), 2015-04, Vol.350 (apr24 2), p.h1857-h1857

2015

Volltextzugriff (PDF)

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Circulation (New York, N.Y.), 2011-05, Vol.123 (21), p.2363-2372

2011

Volltextzugriff (PDF)

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

American journal of ophthalmology, 2018-02, Vol.186, p.116-127

2018

Volltextzugriff (PDF)

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

European heart journal, 2011-11, Vol.32 (22), p.2781-2789

2011

Volltextzugriff (PDF)

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)

American journal of ophthalmology, 2019-04, Vol.200, p.130-137

2019

Volltextzugriff (PDF)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma

Journal of ocular pharmacology and therapeutics, 2018-03, Vol.34 (1-2), p.40-51

2018

Volltextzugriff (PDF)

Perioperative Management of Dabigatran: A Prospective Cohort Study

Circulation (New York, N.Y.), 2015-07, Vol.132 (3), p.167-173

2015

Volltextzugriff (PDF)

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Canadian journal of cardiology, 2014-10, Vol.30 (10), p.1114-1130

2014

Volltextzugriff (PDF)

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Stroke (1970), 2013-06, Vol.44 (6), p.1676-1681

2013

Volltextzugriff (PDF)

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial

Circulation (New York, N.Y.), 2012-07, Vol.126 (3), p.343-348

2012

Volltextzugriff (PDF)

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

Annals of internal medicine, 2011-01, Vol.154 (1), p.1

2011

Volltextzugriff (PDF)

Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran: The RE-LY Trial

Stroke (1970), 2012-06, Vol.43 (6), p.1511-1517

2012

Volltextzugriff (PDF)

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial

Thrombosis and haemostasis, 2011-04, Vol.105 (4), p.721-729

2011

Volltextzugriff (PDF)

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

Circulation (New York, N.Y.), 2013-11, Vol.128 (21), p.2325-2332

2013

Volltextzugriff (PDF)

Netarsudil Ophthalmic Solution 0.02%: First Global Approval

Drugs (New York, N.Y.), 2018-03, Vol.78 (3), p.389-396

Hoy, Sheridan M.

2018

Volltextzugriff (PDF)

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study

Thrombosis and haemostasis, 2012-03, Vol.107 (3), p.584-589

2012

Volltextzugriff (PDF)

Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage

Medicine and science in sports and exercise, 2017-03, Vol.49 (3), p.602-609

2017

Volltextzugriff (PDF)

Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran

Stroke (1970), 2011-12, Vol.42 (12), p.3594-3599

2011

Volltextzugriff (PDF)

1 – 25 von 703

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(644)
Mit Volltextzugriff
(494)

Publikationsform

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(607)
Science & Technology
(554)
Life Sciences & Biomedicine
(546)
Beta-Alanine - Administration & Dosage
(526)
Beta-Alanine - Analogs & Derivatives
(526)
Dabigatran
(417)
Benzimidazoles - Administration & Dosage
(371)
Male
(338)
Anticoagulants - Administration & Dosage
(284)
Female
(240)
Beta-Alanine - Adverse Effects
(229)
Administration, Oral
(226)
Benzimidazoles - Adverse Effects
(215)
Rivaroxaban
(191)
Cardiovascular System & Cardiology
(176)
Atrial Fibrillation - Drug Therapy
(172)
Anticoagulants - Adverse Effects
(156)
Beta-Alanine - Therapeutic Use
(149)
Aged
(148)
Antithrombins - Administration & Dosage
(147)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structured care for patients with new oral anticoagulants. Nursing based care of adults with atrial fibrillation

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma

Perioperative Management of Dabigatran: A Prospective Cohort Study

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran: The RE-LY Trial

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

Netarsudil Ophthalmic Solution 0.02%: First Global Approval

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study

Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage

Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran

Suchergebnisse filtern